Oakville, Ontario–(Newsfile Corp. – January 19, 2022) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on...
Oakville, Ontario–(Newsfile Corp. – November 5, 2021) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol“ or the “Company“), a clinical-stage biotechnology company focused on developing...
Oakville, Ontario–(Newsfile Corp. – October 25, 2021) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol“ or the “Company“), a clinical-stage biotechnology company focused on developing...
Trial designed to investigate the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease...
Oakville, Ontario–(Newsfile Corp. – September 16, 2021) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company“), a clinical-stage biotechnology company focused on developing...
Oakville, Ontario–(Newsfile Corp. – September 10, 2021) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company“), a clinical-stage biotechnology company focused on developing...
Oakville, Ontario–(Newsfile Corp. – September 7, 2021) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company“), a clinical-stage biotechnology company focused on developing...
Oakville, Ontario–(Newsfile Corp. – August 24, 2021) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol“ or the “Company“), a clinical-stage biotechnology company focused on developing...
Oakville, Ontario–(Newsfile Corp. – August 9, 2021) – Cardiol Therapeutics Inc. (TSX: CRDL) (“Cardiol“ or the “Company“), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory...
Oakville, Ontario–(Newsfile Corp. – July 7, 2021) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) (“Cardiol“ or the “Company“), a clinical-stage biotechnology company focused...